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LABORATORY INVESTIGATION
Novel surgical procedures and devices have the potential to improve patient outcomes and safety through the translation of technological advance-
ments to health care. The introduction of robotic devices 
to a number of surgical specialties over the last decade 
has resulted in their application to numerous procedures.6 
Novel medical devices or procedures are associated with 
a learning curve, and patients are exposed to potential 
risks until efficacy can be proven and long-term outcome 
data are acquired.4,15 Surgical device trials have the added 
complication of user-dependent outcomes and the learning 
curve/surgeon contribution to outcomes is difficult to pre-
dict, especially when trying to assess the external validity 
of a particular device or procedure. 
Regulation with regard to the approval of devices varies 
among different countries. A recent cross-sectional study 
showed that fewer than half of devices for which clinical 
studies are undertaken achieve regulatory (FDA) approv-
al.10 Of devices that receive regulatory approval, 43% were 
cleared without the publication of a single clinical study, 
but rather under the 510(k) clearance, where only substan-
tial equivalence to another approved device is necessary. 
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OBJECTIVE The aim of this study was to implement cumulative summation (CUSUM) analysis as an early-warning 
detection and quality assurance system for preclinical testing of the iSYS1 novel robotic trajectory guidance system.
METHODS Anatomically accurate 3D-printed skull phantoms were created for 3 patients who underwent implantation 
of 21 stereoelectroencephalography electrodes by surgeons using the current standard of care (frameless technique). 
Implantation schema were recreated using the iSYS1 system, and paired accuracy measures were compared with the 
previous frameless implantations. Entry point, target point, and implantation angle accuracy were measured on postim-
plantation CT scans. CUSUM analysis was undertaken prospectively.
RESULTS The iSYS1 trajectory guidance system significantly improved electrode entry point accuracies from 1.90 ± 
0.96 mm (mean ± SD) to 0.76 ± 0.57 mm (mean ± SD) without increasing implantation risk. CUSUM analysis was suc-
cessful as a continuous measure of surgical performance and acted as an early-warning detection system. The surgical 
learning curve, although minimal, showed improvement after insertion of the eighth electrode.
CONCLUSIONS The iSYS1 trajectory guidance system did not show any increased risk during phantom preclinical test-
ing when used by neurosurgeons who had no experience with its use. CUSUM analysis is a simple technique that can 
be applied to all stages of the IDEAL (idea, development, exploration, assessment) framework as an extra patient safety 
mechanism. Further clinical trials are required to prove the efficacy of the device.
https://thejns.org/doi/abs/10.3171/2017.8.JNS17936
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Alarmingly, a study of medical devices for orthopedic 
surgery revealed that those approved using the 510(k) 
clearance were 11.5 times more likely to be recalled than 
devices that underwent clinical studies prior to premarket 
approval.5 
The IDEAL (idea, development, exploration, assess-
ment, long-term follow-up) framework is a collaborative 
approach between surgeons and trial methodologists to 
provide structured guidance (similar to that used for drug 
trials) for the transition of medical devices from ideas 
(stage 1) to long-term outcome studies (stage 4).11 The 
IDEAL framework, however, does not provide a continu-
ous method for surgical vigilance toward the early detec-
tion of harm or the potentially negative effect of learning 
curves.
Cumulative summation (CUSUM) analysis is a simple 
early-warning system that compares outcomes of a new in-
tervention or procedure against an established risk or fail-
ure rate that can be used longitudinally to monitor outcome 
and surgical performance.9,20,21 CUSUM analysis has been 
used in prospective robot-assisted randomized control 
trials9 and case control studies in which historical outcome 
data are used to provide a baseline for comparison. The 
latter use has been successfully applied to assess learning 
curves of particular surgical8,24,25 and nonsurgical interven-
tions.2,26 CUSUM analysis acts as an early-warning mecha-
nism to inform investigators if an intervention is exposing 
patients to a higher-than-expected risk of adverse events, 
but does not replace conventional statistical methods.
Stereoelectroencephalography (SEEG) is a neurosurgi-
cal procedure in which multiple electrodes (usually 8–14) 
are placed within the brain to identify the seizure-onset 
zone in patients with drug-refractory focal epilepsy, to 
determine if a resection would be feasible. To date, 4 tech-
niques have been described for the implantation of mul-
tiple intracerebral electrodes, including stereotactic frame–
based,19 frameless,16 robotic,3,12,14 and custom 3D-printed 
fixture methods.1 Electrode trajectories are preplanned to 
ensure that electrodes are a safe distance from intracranial 
arteries and veins,18,22,27 because damage to these vessels 
could result in a life-threating hemorrhage that could cause 
mortality or significant morbidity.13 The accuracy with 
which the electrode conforms to the preplanned trajectory 
is therefore dependent on the implantation method. 
We previously performed a meta-analysis of accura-
cy related to the surgical implantation methodology and 
found a paucity of evidence within the literature compar-
ing implantation techniques.23 Studies to date have been 
of poor quality, amounting to level 3 evidence. There have 
been no prospective comparisons of different implantation 
techniques. Herein, we provide an example in which CU-
SUM analysis was used as an early-warning tool to com-
pare a novel robotic device for the insertion of intracere-
bral SEEG electrodes with the currently used frameless 
technique.16
Methods
SEEG Technique
The frameless implantation technique, which is used as 
the standard of care at the National Hospital for Neurol-
ogy and Neurosurgery, has been described previously.16 
Briefly, the technique involves the use of a mechanical 
arm in combination with a precision aiming device and 
the StealthStation S7 neuronavigation system (Medtronic, 
Inc.). After registration of the patient to the neuronaviga-
tion system using bone fiducial markers as registration 
points, preplanned trajectories on the StealthStation are 
used to align the mechanical arm and the precision aim-
ing device. Using a series of reduction tubes, the trajectory 
is then drilled through the skull and the electrode bolt is 
screwed into the skull. Next, a stylet is passed through the 
bolt and the electrode is inserted to the target point.
In a similar fashion, the novel iSYS1 trajectory guid-
ance system (AS Medizintechnik GmbH) is a small device 
that interfaces with the StealthStation S7 neuronavigation 
system and, through a series of iterative steps, aligns with 
the preplanned trajectory. Similar to the precision aiming 
device, the iSYS1 has a working channel through which 
reduction tubes are placed to allow drilling and insertion 
of the skull bolt followed by the electrode. Both proce-
dures were performed by the same 2 neurosurgeons work-
ing together.
Phantom Generation
Three patients, who underwent a total of 21 electrode 
implantations by surgeons using the conventional frame-
less method, were selected on the basis of a power calcu-
lation, a representative range of anatomical targets, and 
drilling angles to the skull. Skull models for each patient 
were 3D printed (3D Systems, Inc.) with bone fiducials 
in situ using a commercially available realistic bone-like 
substitute (DuraForm PA) and covered with a synthetic 
skin substitute (Fig. 1).
The 2 neurosurgeons who performed implantations in 
the patients repeated the implantation procedure on these 
phantoms, using the iSYS1 robotic trajectory guidance 
system. All equipment, including the drill and electrode 
bolts, was consistent for both implantation techniques. 
The 2 neurosurgeons had seen a demonstration of the 
iSYS1 system and were aware of instructions for its use, 
but had not received any practical training.
FIG. 1. Photograph of implantation using the iSYS1 robotic trajectory 
guidance system on a phantom skull created to replicate SEEG implan-
tation in patients. Figure is available in color online only.
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Following implantation, the 3D-printed skulls under-
went CT scanning. The planned and actual (implanted) 
bolt trajectories were compared using a lateral devia-
tion method (Fig. 2) for the entry point, projected target 
point, and angle error.16 The results were compared with 
the actual postoperative patient implantation for the same 
planned trajectories using EpiNav.17
CUSUM Analysis
CUSUM analysis is calculated using the following 
equation:
dn = (dn-1 + Xin) - Xon
where dn is the CUSUM after n attempts, Xin is the re-sult of the intervention following the nth attempt, and Xo 
is the established risk or failure rate of the control with 
which ongoing attempts are compared. Xo can be calcu-
lated either on a case-by-case basis (Xon), as with paired control trials in this case, or as an overall frequency if 
this is known. When dn is plotted for subsequent attempts, the gradient of the graph provides information regard-
ing whether the intervention is performing better (nega-
tive gradient) or worse (positive gradient) than the control 
intervention. A change in the gradient from negative to 
positive following the introduction of a new intervention 
therefore serves as an early warning that outcomes are 
worse than in the control group, even though this may not 
have reached statistical significance. Each of the electrode 
bolt insertion accuracies using the iSYS1 on the phantom 
(Xin) were compared with the patient insertions using the frameless technique (Xon). Analysis was also done using a 3-mm-accuracy safety margin based on accuracy data 
provided by Cardinale et al.3
Statistical Analysis
The power calculation assumed a significance level of a 
= 0.05, power of 1 - b = 0.95, to detect a 0.8-mm improve-
ment in entry point accuracy with an estimated standard 
deviation of 0.7 mm based on previously published data.7 
According to this calculation, paired results from 20 elec-
trodes would be required. Following implantation, paired 
electrode bolt insertion accuracies for the entry point, pro-
jected target point, and angle error were tested using both 
the Kolmogorov-Smirnov and Shapiro-Wilk tests to con-
firm a Gaussian distribution. Next, Student’s paired t-test 
(2-tailed) was performed using SPSS version 24.
Results
Phantom Testing Accuracy
Comparison of the frameless insertion of SEEG elec-
trodes in the patients with the iSYS1 system on the 3D 
phantoms resulted in a statistically significant (p < 0.01) 
improvement in the entry point accuracy from 1.90 ± 0.96 
mm (mean ± SD) to 0.76 ± 0.57 mm (mean ± SD), respec-
tively. Projected target point accuracy improved from 1.72 
± 0.98 mm (mean ± SD) to 1.34 ± 0.86 mm (mean ± SD), 
but was not statistically significant (p = 0.17). Angle er-
ror from the plan nonsignificantly improved from 0.95° 
± 0.39° (mean ± SD) to 0.88° ± 0.55° (mean ± SD) (p = 
0.59) (Fig. 3).
CUSUM Analysis Results
The CUSUM analyses for entry point, target point, and 
angle error are shown in Fig. 4. The entry point and target 
point plots reveal a negative trend line with high correla-
tion (R2 = 0.98 and 0.69, respectively), indicating that the 
iSYS1 implantation technique was beneficial and did not 
increase risk. The CUSUM analysis for angle error, how-
ever, showed wide variation with poor correlation (R2 = 
0.15), suggesting that the implantation method had little or 
no effect on this measurement.
Learning Curve Assessment
The end of the learning process is where the positive 
gradient of the curve becomes negative or where the gra-
dient becomes most negative. CUSUM analysis curves 
(Fig. 4) suggest that the overall learning effect was mini-
mal and that the maximal improvement with iSYS1 com-
pared with the frameless technique occurred after the 
eighth electrode.
Discussion
The transition of medical devices to the clinical set-
ting through use by early adopters of technology has the 
potential to cause patient harm before the long-term risks 
and benefits can be determined through methodologically 
sound clinical trials. In contrast to drug trials, where phase 
I and II trials are performed in small numbers of patients 
to prevent harm, only 60% of devices were found to have 
published clinical trials prior to attaining regulatory ap-
proval.
The IDEAL collaboration is an attempt to provide a 
framework for device trials analogous to that of a drug tri-
al, in which small-scale studies are performed using fewer 
patients to determine the device’s safety and efficacy pri-
FIG. 2. Schematic of implantation accuracy metrics including entry point, 
projected target point, and angle error to skull. The solid line (diamond) 
indicates the planned electrode and the dashed line (circle) indicates the 
bolt axis trajectory. Entry point (a) and projected target point (b) error 
were measured as lateral deviation from the plan.
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or to larger comparative studies in which long-term data 
can be gathered. During this period, robust early-warning 
mechanisms are required that will detect any potentially 
deleterious effects of the device and thereby prevent pa-
tient harm. Herein, we used CUSUM analysis to compare 
paired electrode insertions in an anatomically accurate 
phantom using the iSYS1 robotic trajectory guidance sys-
tem with a frameless implantation performed in patients.
Comparison With Other Studies
CUSUM analysis has been used in a number of surgi-
cal and nonsurgical fields to assess the learning curve of 
operators and as a continuous quality assurance indica-
tor. Through the collection of prospective outcomes, real-
time comparisons can be made among prospective control 
groups, retrospective cohorts, or previously established 
risk/failure rates. Currently, the main use of CUSUM 
analysis is to assess surgeon learning curves and training 
for new techniques. However, CUSUM analysis also has 
the potential to be applied as a quality assurance indicator, 
to surgeon revalidation, and as an early-warning detector 
in clinical trials.
To date, there have been no prospective control trials 
comparing SEEG insertion techniques. This is probably 
due to the requirement for a single unit to have a surgeon 
or group of surgeons who are capable of performing more 
than one implantation technique. There is some evidence 
from studies in which one technique has replaced another. 
Cardinale et al.3 compared historical SEEG electrode im-
plantation accuracy using the Talairach frame with that 
of the neuromate robot (Renishaw). No prospective con-
trolled trial data are available to suggest the superiority of 
one over the other. Given that the neuromate robot is now 
the standard of care in Cardinale and associates’ unit, it 
would be ethically challenging to perform a prospective 
trial comparing it with the previous technique.
The scenario of a single neurosurgical unit not hav-
ing the surgical expertise to use more than one technique 
could be overcome through multicenter trials, but individ-
ual surgeon–specific performance is difficult to account 
for methodologically. Furthermore, the comparison of 
techniques between different units may introduce a sys-
tematic bias. Another important consideration is how the 
learning effect will be overcome when comparing a new 
technique that has less familiarity among surgeons with 
one that has been established. CUSUM analysis may over-
come this.
Using paired electrode data, we showed that the perfor-
mance of a novel device can be continuously monitored, 
and any change in safety performance over time can be 
detected. By recreating an anatomically accurate phantom 
replica of a patient’s skull using 3D printing technology, 
the same electrode trajectories could be implemented by 
the same surgeons to control for any systemic bias. During 
clinical trials, data monitoring committees are established 
to preside over serious adverse events and have the power 
to close trials prematurely when one arm of a trial shows 
significant benefit over another. 
For an adverse event to reach statistical significance, 
a significant number of patients are exposed to risk. Our 
prospective power calculation revealed that 20 electrodes 
would be needed to statistically detect a 0.8-mm improve-
ment in entry point accuracy. CUSUM analysis cannot 
replace statistical tests. However, it does allow trends in 
beneficial or adverse events to be monitored closely, and 
it could potentially alert investigators to deleterious out-
comes before they become statistically significant. We 
found that by using the iSYS1 trajectory guidance system, 
implantation entry point accuracies were significantly im-
proved (p < 0.01) from 1.90 ± 0.96 mm (mean ± SD) with 
the frameless technique to 0.76 ± 0.57 mm (mean ± SD). 
These results are consistent with a study by Dorfer et 
FIG. 3. A: Comparison of entry point, target point, and entry angle deviations from plan with manual patient and iSYS1 phantom 
implantations. B: Suggested grading system for clinical relevance of implantation error and proportion of manual patient and 
iSYS1 phantom electrodes within error tolerances. EP = entry point; TP = target point. Figure is available in color online only.
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al.,7 in which preclinical testing of the iSYS1 device im-
proved entry point accuracy to 0.6 ± 0.4 mm (mean ± SD) 
from 1.4 ± 0.5 mm (mean ± SD) with the frameless tech-
nique. The same group also reported entry point accuracy 
of 1.18 ± 0.5 mm (mean ± SD) for 93 electrodes in 16 pa-
tients, after slight modification of the technique. Cardinale 
et al.3 found a mean entry point accuracy of 0.78 mm using 
the neuromate robot for SEEG, and Mullin et al.14 found 
a mean entry point accuracy of 1.2 mm using the ROSA 
system.
Based on these accuracy data, Cardinale et al. recom-
mended the institution of a safety margin of 3 mm accord-
ing to the following formula:
Safety margin = bolt diameter + mean error + 3 SD
One percent of electrodes would deviate outside of a 
3-SD safety margin, which was deemed acceptable. When 
the CUSUM analysis was repeated on the basis of a 3-mm 
entry point safety margin and an accepted 1% violation 
rate, the iSYS1 device performed within this threshold for 
all implanted electrodes.
Study Limitations
Limitations of our study include the small sample (21 
electrodes) and differences in the use of a 3D-printed 
phantom compared with a patient. We tried to use a mate-
rial that had similar properties to real bone, but the bone 
substitute was slightly harder.
The control group was derived from in vivo frameless 
implantations. We accept that it may have been method-
ologically better if the frameless implantation method 
was also used on the phantoms. We compared the same 
surgeons to prevent intersurgeon variability, but they had 
more experience with the frameless technique than with 
the iSYS1 robotic device. We found that there was a mini-
mal learning curve associated with first-time use of the 
iSYS1 device. At all times, entry point accuracy was found 
to be higher with the iSYS1 device than with the frameless 
technique.
We do not believe that experience gained through im-
plantation of electrodes in patients using the frameless 
method would have resulted in an increase in the accuracy 
of the iSYS1 phantom implantations. This is because the 
robotic implantations were performed many months after 
the implantations in patients. Furthermore, given that the 
iSYS1 trajectory guidance system performs the alignment 
automatically, we cannot envisage how prior experience 
with the patients’ skulls could improve the accuracy of the 
implantation.
FIG. 4. CUSUM analyses for entry point error (A), target point error (B), and angle error (C). A negative gradient implies that the 
intervention (iSYS1) is more beneficial than the control (frameless) implantation. Any change to a positive gradient should alert 
investigators to an increase in potential risk of the implantation (as can be seen between electrodes 6 and 8 in panel B). The end of 
the learning curve is taken as the point where the positive gradient becomes negative or where the gradient becomes most nega-
tive. In panel A, the learning curve for entry point error becomes most negative after the implantation of electrode 8. In panel B, 
the target point error becomes negative after the implantation of electrode 9. In panel C, the angle error learning curve becomes 
negative after the implantation of electrode 12, but there is poor correlation between the intervention and angle error. Figure is 
available in color online only.
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We focused more on entry point accuracy than target 
point accuracy. The reason is that entry point accuracy 
and angle are the main factors that can be controlled by 
the surgeon. Given that the electrodes are flexible and 
inserted in a blind fashion, there is a potential for them 
to deviate within the brain. Our phantoms did not have 
brain material within them and, as such, we could not ac-
curately compare actual target points. To account for this, 
we calculated projected target points based on the bolt tip 
and extrapolated these data to a uniform distance for both 
manual and iSYS1 implantations. The majority of intra-
cranial hemorrhages following SEEG implantation are ex-
traaxial, most likely as a result of damage to cortical veins. 
Although there does remain a risk of hemorrhage along 
the entire intracranial length of the electrode, small inac-
curacies at the target are unlikely to prevent measurement 
of the interictal and ictal electrophysiology from the target 
structure of interest.
Conclusions
The introduction of novel medical devices to clinical 
practice has inherent risk. A large proportion of devices 
are approved without rigorous clinical trial data or long-
term follow-up. In this study, we have shown that CUSUM 
analysis is an effective tool for the assessment of a novel 
robotic device for SEEG electrode insertion. As part of 
preclinical testing, we recreated implantation schemes and 
implemented these using an anatomically accurate skull 
phantom. Entry point accuracy was statistically improved 
using the iSYS1 robotic trajectory guidance system. 
CUSUM analysis can be used as an early-warning tool in 
conjunction with all stages of the IDEAL framework to 
enhance patient safety. A thorough independent appraisal 
of clinical and economic factors is required before medical 
devices can be widely adopted. Even with the use of meth-
odologically sound clinical trials, patients are exposed to 
potential risks. It is an ethical obligation incumbent on all 
trial investigators to mitigate this risk to the extent possible 
through the early detection of complications.
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